MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-14-0053073
Medicvista Pharma Private Limited
Medicvista Pharma Private Limited - trading in Jalgaon, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹81.12 Lakh
▲ 43% YoY
Net profit · FY 2024
₹54,398
Net margin 0.7%
EBITDA · FY 2024
₹2.83 Lakh
EBITDA margin 3.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
14 yrs
Est. 2012
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Medicvista Pharma Private Limited
Data last updated:
Medicvista Pharma Private Limited is a private limited company based in Jalgaon, Maharashtra, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 11 June 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74900MH2012PTC232027. Its GSTIN is 27AAHCM9923C1ZD (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Bhushan Vamanrao Zambare and Vaman Gopal Zambare.
Its last annual general meeting (AGM) was held on 23 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 361 Gandhi Chowk At & Post Varangaon Tal. Bhusawal, Jalgaon, Maharashtra, India – 425305.
As per the financials filed for FY 2024, the company reported a revenue of ₹81.12 Lakh, a growth of 43% compared to the previous year. For the same year it recorded a net profit of ₹54,398 (net margin 0.7%) and EBITDA of ₹2.83 Lakh (EBITDA margin 3.5%). Revenue has grown at a compounded annual rate (CAGR) of 14% over five years.
Medicvista Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-14-0053073). The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
CIN U74900MH2012PTC232027
Registration Number 232027
Incorporation Date 11 June 2012
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 23 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Non-Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-14-0053073
Recognitions & Rankings of Medicvista Pharma
Contact details
Medicvista Pharma Private Limited's registered office is in Jalgaon, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address361 Gandhi Chowk At & Post Varangaon Tal. Bhusawal, Jalgaon, Maharashtra, India – 425305
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Medicvista Pharma Private Limited, buy the company report.
Comprehensive company report
Medicvista Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Medicvista Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Medicvista Pharma Private Limited, buy the company report.
Financials of Medicvista Pharma Private Limited
FY 2024 filings availableMedicvista Pharma Private Limited reported revenue of ₹81.12 Lakh (up 43% YoY) for FY 2024.
Revenue · FY 2024
₹81.12 Lakh ▲ 43%
Net profit · FY 2024
₹54,398 margin 0.7%
EBITDA · FY 2024
₹2.83 Lakh margin 3.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 43%
5 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▲ 121%
5 years · compounded
▲ 51%
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 43% growth in the latest year. EBITDA rose 121% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.83 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹54,398 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.5% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medicvista Pharma Private Limited, buy the company report.
Board of directors of Medicvista Pharma Private Limited
Medicvista Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhushan Vamanrao Zambare | Director | 11 Jun 2012 | 14 Years 4 Months | Current |
| Vaman Gopal Zambare | Director | 11 Jun 2012 | 14 Years 4 Months | Current |
Peer comparison
Medicvista Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rishit Medicare Private Limited | ₹81.43 Lakh (FY 2024) | 298.0% | Barwani, Madhya Pradesh, India | |||
| Sushrut Eye Hospital Private Limited | ₹81.22 Lakh (FY 2024) | 115.0% | Lucknow, Uttar Pradesh, India | |||
| Viveka Medical Research Foundation | ₹81.17 Lakh (FY 2025) | 8017.0% | Nagpur, Maharashtra, India | |||
| Sahara Carediagnostic Private Limited | ₹81.16 Lakh (FY 2024) | 12.0% | Delhi, India | |||
| Sevvel Healthcare Management Private Limited | ₹81.16 Lakh (FY 2023) | 31.0% | Chennai, Tamil Nadu, India | |||
| Medicvista Pharma Private Limitedthis company | ₹81.12 Lakh (FY 2024) | ₹54,398 | 0.7% | 43.0% | Jalgaon, Maharashtra, India | |
| Paedi Care Hospital Private Limited | ₹80.89 Lakh (FY 2025) | 0.0% | Patna, Bihar, India | |||
| Restora Care-Advanced Health Private Limited | ₹80.88 Lakh (FY 2025) | -13.0% | Noida, Uttar Pradesh, India | |||
| Cresta Medicare Private Limited | ₹80.85 Lakh (FY 2021) | Thiruvananthapuram, Kerala, India | ||||
| Biogennext Healthplus (OPC) Private Limited | ₹80.81 Lakh (FY 2024) | -34.0% | New Delhi, Delhi, India | |||
| Espee Dynamed Equipments Private Limited | ₹80.79 Lakh (FY 2025) | -34.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Medicvista Pharma Private Limited, buy the company report.
Auditor
Medicvista Pharma Private Limited is audited by H.R. WAYKOLE AND CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| H.R. WAYKOLE AND CO | FY 2017 | 032084 |
Shareholding
The shareholding of Medicvista Pharma Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Medicvista Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medicvista Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medicvista Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medicvista Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCM9923C1ZD | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medicvista Pharma Private Limited, buy the company report.
Recent activity
Medicvista Pharma Private Limited has 2 board changes on record since 2012: 2 appointments. The latest: Bhushan Vamanrao Zambare was appointed as Director on 11 Jun 2012.
AGM
Medicvista Pharma Private Limited last Annual general meeting of members was held on 23 Sep 2024 as per latest MCA records.
Filing
Medicvista Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai Ii.
Appointed
Bhushan Vamanrao Zambare was appointed as Director.
Appointed
Vaman Gopal Zambare was appointed as Director.
Incorporation
11 Jun 2012
Medicvista Pharma Private Limited was registered on 11 Jun 2012 with Roc Mumbai Ii & aged 14 years 4 months as per MCA records.
Frequently asked questions
Medicvista Pharma is an active private limited company based in Jalgaon, Maharashtra, India. The company works in wholesale, within the trading industry. It was incorporated on 11 June 2012 (14+ years old) and is registered under CIN U74900MH2012PTC232027.
Medicvista Pharma has 2 current directors:
- Bhushan Vamanrao Zambare - Director
- Vaman Gopal Zambare - Director
The latest financial statements of Medicvista Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 23 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Medicvista Pharma is 27AAHCM9923C1ZD, registered in Maharashtra.
The CIN (Corporate Identification Number) of Medicvista Pharma is U74900MH2012PTC232027. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medicvista Pharma was incorporated on 11 June 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Medicvista Pharma by revenue are Rishit Medicare Private Limited, Sushrut Eye Hospital Private Limited, Viveka Medical Research Foundation, Sahara Carediagnostic Private Limited, Sevvel Healthcare Management Private Limited and 5 more, all in the same principal business activity (other hospital and medical care activities).
Bhushan Vamanrao Zambare was appointed as Director on 11 Jun 2012. Vaman Gopal Zambare was appointed as Director on 11 Jun 2012.
Yes, Medicvista Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-14-0053073).
The registered office of Medicvista Pharma is at 361 Gandhi Chowk At & Post Varangaon Tal. Bhusawal, Jalgaon, Maharashtra, India – 425305.
Medicvista Pharma operates in the trading industry, in the wholesale segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages